Health Catalyst, INC Form 4 insider transactions

Green Jill Hoggard, a Director of Health Catalyst, Inc., received 80,691 shares of common stock on July 16, 2026.

Julie Larson-Green, a Director of Health Catalyst, Inc., received 80,691 shares of common stock on July 16, 2026.

Steven H Nelson, a Director of Health Catalyst, Inc., received 80,691 shares of common stock on July 16, 2026.

Justin Spencer, a Director of Health Catalyst, Inc., received 80,691 shares of common stock on July 16, 2026.

Health Catalyst CEO Albert Benjamin reported a transaction involving the sale of 34,485 shares to cover tax withholding obligations upon the vesting of restricted stock units.

CEO Benjamin Albert disposed of 336 shares of Health Catalyst, Inc. to satisfy tax withholding obligations.

Chief People Officer Linda Llewelyn disposed of 8,519 shares of Health Catalyst common stock to satisfy tax withholding obligations.

Health Catalyst CFO Jason Alger sold 18,804 shares to satisfy tax withholding obligations related to RSU vesting.

General Counsel Benjamin Landry disposed of 13,779 shares of Health Catalyst, Inc. to satisfy tax withholding obligations.

Health Catalyst, Inc. director Julie Larson-Green was granted 12,710 restricted stock units that vested immediately on June 1, 2026.

Health Catalyst, Inc. reports that Director Steven H. Nelson was granted restricted stock units (RSUs) on May 1, 2026, with vesting scheduled over three years.

Health Catalyst CEO Benjamin Albert disposed of 70,455 shares of common stock to cover tax withholding obligations related to RSU vesting.

Health Catalyst's General Counsel, Benjamin Landry, disposed of 20,838 shares of common stock to cover tax withholding obligations related to RSU vesting.

Health Catalyst's Chief Financial Officer, Jason Alger, sold 26,970 shares of common stock to cover tax withholding obligations related to RSU vesting.

Health Catalyst CEO Albert Benjamin disposed of 4,966 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Health Catalyst Director Julie Larson-Green acquired 8,361 shares of common stock through RSU vesting on March 1, 2026.

Health Catalyst's Chief People Officer, Linda Llewelyn, disposed of 13,836 shares of common stock to cover tax withholding obligations related to vested Restricted Stock Units.

Health Catalyst CEO Benjamin Albert reported the acquisition of over 968,000 restricted stock units and performance-based restricted units, alongside a tax-related stock disposition.

Health Catalyst's Chief People Officer, Linda Llewelyn, reported the acquisition of restricted stock units and performance-based restricted units, alongside a mandatory 'sell to cover' transaction for tax obligations.

Health Catalyst General Counsel Benjamin Landry reported significant equity awards, including restricted stock units and performance-based units, alongside a tax-related 'sell to cover' transaction.

Health Catalyst's Chief Financial Officer, Jason Alger, reported significant equity awards, including restricted stock units and performance-based restricted units, alongside a tax-related share disposition.

Health Catalyst Director Duncan Gallagher reported the vesting of 7,562 restricted stock units on February 17, 2026.

Health Catalyst General Counsel Benjamin Landry sold 27,425 shares of common stock for $2.6373 per share under a pre-arranged 10b5-1 trading plan.

Health Catalyst Director Julie Larson-Green reported the sale of 47,997 shares of common stock at $2.6741 per share, executed under a pre-arranged 10b5-1 trading plan.

Health Catalyst Director Julie Larson-Green was granted 5,731 restricted stock units, vesting on December 1, 2025, increasing her beneficial ownership to 121,570 shares.

Health Catalyst Director Duncan Gallagher reported the vesting of 6,209 restricted stock units on December 1, 2025.

Health Catalyst's General Counsel, Benjamin Landry, sold 14,387 shares of common stock to cover tax withholding obligations related to vested Restricted Stock Units.

Health Catalyst's Chief People Officer, Linda Llewelyn, disposed of 9,762 shares of common stock to cover tax withholding obligations related to vested Restricted Stock Units.

Health Catalyst's Chief Commercial Officer, Kevin Lee Freeman, sold 16,401 shares of common stock to cover tax withholding obligations related to vested Restricted Stock Units.

Health Catalyst's Chief Financial Officer, Jason Alger, disposed of 20,619 common shares in a non-discretionary 'sell to cover' transaction related to RSU vesting.